Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Susana Seixas & Patricia Isabel Marques. (2021) Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum. The Application of Clinical Genetics 14, pages 173-194.
Read now
Read now
Franck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, Tatsiana Beiko & Charlie Strange. (2020) Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3193-3199.
Read now
Read now
Leonor Meira, Rita Boaventura, Susana Seixas & Maria Sucena. (2018) Alpha-1 Antitrypsin Deficiency Detection in a Portuguese Population. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:1, pages 4-9.
Read now
Read now
Ross G Edgar, Mitesh Patel, Susan Bayliss, Diana Crossley, Elizabeth Sapey & Alice M Turner. (2017) Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1295-1308.
Read now
Read now
Eeva Piitulainen, Behrouz Mostafavi & Hanan A Tanash. (2017) Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37–40 years. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 495-500.
Read now
Read now
Yotam Lior, Assaf Geyra & Eli C Lewis. (2016) Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 – 2015). Expert Opinion on Therapeutic Patents 26:5, pages 581-589.
Read now
Read now
Sanjay H Chotirmall, Mazen Al-Alawi, Thomas McEnery & Noel G McElvaney. (2015) Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes. Therapeutics and Clinical Risk Management 11, pages 143-151.
Read now
Read now
Concetta Gardi, Blerta Stringa & Piero A Martorana. (2015) Animal models for anti-emphysema drug discovery. Expert Opinion on Drug Discovery 10:4, pages 399-410.
Read now
Read now
Heather S Loring & Terence R Flotte. (2015) Current status of gene therapy for α-1 antitrypsin deficiency. Expert Opinion on Biological Therapy 15:3, pages 329-336.
Read now
Read now
Shuling Guo, Sheri L Booten, Andrew Watt, Luis Alvarado, Susan M Freier, Jeffery H Teckman, Michael L McCaleb & Brett P Monia. (2014) Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. Rare Diseases 2:1.
Read now
Read now
Articles from other publishers (77)
Alberto Quaglia, Eve A. Roberts & Michael Torbenson. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
122
294
.
Jean-François Mornex, Julie Traclet, Olivier Guillaud, Magali Dechomet, Christine Lombard, Mathias Ruiz, Didier Revel, Philippe Reix & Vincent Cottin. (2023) Alpha1-antitrypsin deficiency: An updated review. La Presse Médicale 52:3, pages 104170.
Crossref
Crossref
Etevaldo Deves Fernandes Neto, Fladimir de Lima Gondim, Marcelle Ferreira Moura, Ruth Mesquita Ferreira, Leidianne Costa da Silva Andrade, Antônia Torres Ávila Pimenta, Daniel Silveira Serra & Francisco Sales Ávila Cavalcante. (2023) ASSESSMENT OF INDOOR SECOND-HAND CIGARETTE SMOKE ON THE RESPIRATORY MECHANICS AND PREVENTIVE BENEFITS OF EUCALYPTOL: A MURINE MODEL. Environmental Smoke 6:2, pages 46-57.
Crossref
Crossref
Nurdan Kokturk, Nazli Khodayari, Jorge Lascano, E. Leonard Riley & Mark L. Brantly. (2023) Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function. Respiratory Research 24:1.
Crossref
Crossref
Stephen G. J. Smith & Catherine M. Greene. (2023) Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy. Non-Coding RNA 9:1, pages 6.
Crossref
Crossref
Arce Domingo-Relloso, Angela L. Riffo-Campos, Martha Powers, Maria Tellez-Plaza, Karin Haack, Robert H. Brown, Jason G. Umans, M. Daniele Fallin, Shelley A. Cole, Ana Navas-Acien & Tiffany R. Sanchez. (2022) An epigenome-wide study of DNA methylation profiles and lung function among American Indians in the Strong Heart Study. Clinical Epigenetics 14:1.
Crossref
Crossref
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, Yang Ji, Yunjiao He & Peng George Wang. (2022) Self-Amplifying RNA Approach for Protein Replacement Therapy. International Journal of Molecular Sciences 23:21, pages 12884.
Crossref
Crossref
J.-F. Mornex. (2022) Le déficit en alpha 1-antitrypsine. Revue des Maladies Respiratoires 39:8, pages 698-707.
Crossref
Crossref
J.-F. Mornex, M. Balduyck, A. Cuvelier, V. Cottin & H. Mal. (2022) Des recommandations françaises pour le déficit en alpha1-antitrypsine ; enfin !. Revue des Maladies Respiratoires 39:7, pages 575-577.
Crossref
Crossref
J.-F. Mornex, M. Balduyck, M. Bouchecareilh, A. Cuvelier, R. Epaud, M. Kerjouan, O. Le Rouzic, C. Pison, L. Plantier, M.-C. Pujazon, M. Reynaud-Gaubert, A. Toutain, B. Trumbic, M.-C. Willemin, M. Zysman, O. Brun, M. Campana, F. Chabot, V. Chamouard, M. Dechomet, J. Fauve, B. Girerd, C. Gnakamene, S. Lefrançois, J.-N. Lombard, B. Maitre, C. Maynié-François, A. Moerman, A. Payancé, P. Reix, D. Revel, M.-P. Revel, M. Schuers, P. Terrioux, D. Theron, F. Willersinn, V. Cottin & H. Mal. (2022) Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge. Revue des Maladies Respiratoires 39:7, pages 633-656.
Crossref
Crossref
Surajit Dey, Mathew Suji Eapen, Collin Chia, Archana Vijay Gaikwad, Peter A. B. Wark & Sukhwinder Singh Sohal. (2022) Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities. American Journal of Physiology-Lung Cellular and Molecular Physiology 322:1, pages L64-L83.
Crossref
Crossref
Timm Greulich & Martina Veith. 2022. Seltene Lungenerkrankungen. Seltene Lungenerkrankungen
495
512
.
Inga Jarosch & Andreas Rembert Koczulla. (2021) Genetische Ursachen der chronisch obstruktiven Lungenerkrankung (COPD)Genetic causes of chronic obstructive pulmonary disease (COPD). Wiener klinisches Magazin 24:6, pages 234-239.
Crossref
Crossref
Sun Young Jung, Gun-Dong Kim, Dae Woon Choi, Dong-Uk Shin, Ji-Eun Eom, Seung Yong Kim, Ok Hee Chai, Hyun-Jin Kim, So-Young Lee & Hee Soon Shin. (2021) Epilobiumpyrricholophum Extract Suppresses Porcine Pancreatic Elastase and Cigarette Smoke Extract-Induced Inflammatory response in a Chronic Obstructive Pulmonary Disease Model. Foods 10:12, pages 2929.
Crossref
Crossref
Caspar Schiffers, Niki L. Reynaert, Emiel F. M. Wouters & Albert van der Vliet. (2021) Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies. Antioxidants 10:11, pages 1799.
Crossref
Crossref
Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, Beatrice Molena, Sara Lococo, Alessia Achille, Federico Lionello, Leonardo Salviati, Marco Caminati & Gianenrico Senna. (2021) Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. Journal of Clinical Medicine 10:19, pages 4493.
Crossref
Crossref
Inga Jarosch & Andreas Rembert Koczulla. (2021) Genetische Ursachen der chronisch obstruktiven Lungenerkrankung (COPD)Genetic causes of chronic obstructive pulmonary disease (COPD). Der Pneumologe 18:4, pages 226-232.
Crossref
Crossref
Angélique Rivot, Natacha Jugniot, Samuel Jacoutot, Nicolas Vanthuyne, Philippe Massot, Philippe Mellet, Sylvain R.A. Marque, Gérard Audran, Pierre Voisin, Marie Delles, Gilles Devouassoux, Eric Thiaudiere, Abderrazzak Bentaher & Elodie Parzy. (2021) Magnetic Resonance Imaging of Protease-Mediated Lung Tissue Inflammation and Injury. ACS Omega 6:23, pages 15012-15016.
Crossref
Crossref
Gillian A. Kelly-Robinson, James A. Reihill, Fionnuala T. Lundy, Lorcan P. McGarvey, John C. Lockhart, Gary J. Litherland, Keith D. Thornbury & S. Lorraine Martin. (2021) The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases. International Journal of Molecular Sciences 22:12, pages 6351.
Crossref
Crossref
Francesco Callea, Paola Francalanci & Isabella Giovannoni. (2021) Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. International Journal of Molecular Sciences 22:11, pages 5778.
Crossref
Crossref
Grace Hogan, Pierce Geoghegan, Tomás P. Carroll, Jennifer Clarke, Oisín F. McElvaney, Oliver J. McElvaney, Noel G. McElvaney & Gerard F. Curley. (2021) α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?. Anesthesiology 134:5, pages 792-808.
Crossref
Crossref
Anna Annunziata, Ilaria Ferrarotti, Antonietta Coppola, Maurizia Lanza, Pasquale Imitazione, Sara Spinelli, Pierpaolo Di Micco & Giuseppe Fiorentino. (2021) Alpha-1 Antitrypsin Screening in a Selected Cohort of Patients Affected by Chronic Pulmonary Diseases in Naples, Italy. Journal of Clinical Medicine 10:8, pages 1546.
Crossref
Crossref
Francesco Callea & Valeer Desmet. (2021) The Discovery of Endoplasmic Reticulum Storage Disease. The Connection between an H&E Slide and the Brain. International Journal of Molecular Sciences 22:6, pages 2899.
Crossref
Crossref
Nan Wang, Qin Wang, Tiantian Du, Abakundana Nsenga Ariston Gabriel, Xue Wang, Li Sun, Xiaomeng Li, Kanghong Xu, Xinquan Jiang & Yi Zhang. (2021) The Potential Roles of Exosomes in Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 7.
Crossref
Crossref
Jan Sieluk, Julia F. Slejko, Henry Silverman, Eleanor Perfetto & C. Daniel Mullins. (2020) Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Naoya Tanabe, Dragoş M. Vasilescu, Cameron J. Hague, Kohei Ikezoe, Darra T. Murphy, Miranda Kirby, Christopher S. Stevenson, Stijn E. Verleden, Bart M. Vanaudenaerde, Ghislaine Gayan-Ramirez, Wim Janssens, Harvey O. Coxson, Peter D. Paré & James C. Hogg. (2020) Pathological Comparisons of Paraseptal and Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 202:6, pages 803-811.
Crossref
Crossref
Roxana Cortes-Lopez & Igor Barjaktarevic. (2020) Alpha-1 Antitrypsin Deficiency: a Rare Disease?. Current Allergy and Asthma Reports 20:9.
Crossref
Crossref
M. Sucena, J. Gomes, C. Guimarães & M. Miravitlles. (2020) Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now. Pulmonology 26:4, pages 181-183.
Crossref
Crossref
Ahmad Karadagi, Alex G. Cavedon, Helen Zemack, Greg Nowak, Marianne E. Eybye, Xuling Zhu, Eleonora Guadagnin, Rebecca A. White, Lisa M. Rice, Andrea L. Frassetto, Stephen Strom, Carl Jorns, Paolo G. V. Martini & Ewa Ellis. (2020) Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency. Scientific Reports 10:1.
Crossref
Crossref
Maria C. Basil & Edward E. Morrisey. (2020) Lung regeneration: a tale of mice and men. Seminars in Cell & Developmental Biology 100, pages 88-100.
Crossref
Crossref
G. V. Volynets & A. V. Nikitin. (2020) Pathophysiological aspects of liver damage in children with alpha-1-antitrypsin deficiency. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 65:1, pages 11-21.
Crossref
Crossref
Nancy T. Malintan, Steven D. Buckingham, David A. Lomas & David B. Sattelle. (2019) Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin. Scientific Reports 9:1.
Crossref
Crossref
Josep Montserrat-Capdevila, Pere Godoy, Josep Ramon Marsal, Marta Ortega, Ferran Barbé, Maria Teresa Castañ, María Asunción Seminario, Jesús Pujol & Miquel Alsedà. (2019) Prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores. Atención Primaria 51:9, pages 589-590.
Crossref
Crossref
Chiara Rigobello, Simonetta Baraldo, Mariaenrica Tinè, Ilaria Ferrarotti, Angelo Guido Corsico, Erica Bazzan, Graziella Turato, Elisabetta Balestro, Davide Biondini, Giorgio Valle, Marina Saetta & Manuel G. Cosio. (2019) Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency. Scientific Reports 9:1.
Crossref
Crossref
Esra Karatas, Sylvaine Di-Tommaso, Nathalie Dugot-Senant, Alain Lachaux & Marion Bouchecareilh. (2019) Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease. EMJ Hepatology, pages 65-79.
Crossref
Crossref
Itishri Sahu, A.K.M. Ashiqul Haque, Brian Weidensee, Petra Weinmann & Michael S.D. Kormann. (2019) Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases. Molecular Therapy 27:4, pages 803-823.
Crossref
Crossref
Alisha M. Gruntman & Terence R. Flotte. 2019. Muscle Gene Therapy. Muscle Gene Therapy
775
786
.
I. Suárez-Lorenzo, F. Rodríguez de Castro, D. Cruz-Niesvaara, E. Herrera-Ramos, C. Rodríguez-Gallego & T. Carrillo-Diaz. (2018) Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites. Clinical and Translational Allergy 8:1.
Crossref
Crossref
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Crossref
Dandi Qiao, Asher Ameli, Dmitry Prokopenko, Han Chen, Alvin T Kho, Margaret M Parker, Jarrett Morrow, Brian D Hobbs, Yanhong Liu, Terri H Beaty, James D Crapo, Kathleen C Barnes, Deborah A Nickerson, Michael Bamshad, Craig P Hersh, David A Lomas, Alvar Agusti, Barry J Make, Peter M A Calverley, Claudio F Donner, Emiel F Wouters, Jørgen Vestbo, Peter D Paré, Robert D Levy, Stephen I Rennard, Ruth Tal-Singer, Margaret R Spitz, Amitabh Sharma, Ingo Ruczinski, Christoph Lange, Edwin K Silverman & Michael H Cho. (2018) Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. Human Molecular Genetics 27:21, pages 3801-3812.
Crossref
Crossref
Charis-Patricia Segeritz, Sheikh Tamir Rashid, Miguel Cardoso de Brito, Maria Paola Serra, Adriana Ordonez, Carola Maria Morell, Joseph E. Kaserman, Pedro Madrigal, Nicholas R.F. Hannan, Laurent Gatto, Lu Tan, Andrew A. Wilson, Kathryn Lilley, Stefan J. Marciniak, Bibek Gooptu, David A. Lomas & Ludovic Vallier. (2018) hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency. Journal of Hepatology 69:4, pages 851-860.
Crossref
Crossref
Wei Zhu, Lanfen Li, Mingjing Deng, Bo Wang, Mengfei Li, Guofang Ding, Zuisu Yang, Dan Medynski, Xiaotao Lin, Ying Ouyang, Jirui Lin, Luyuan Li & Xinli Lin. (2018)
Oxidation‐resistant and thermostable forms of alpha‐1 antitrypsin from
Escherichia coli
inclusion bodies
. FEBS Open Bio 8:10, pages 1711-1721.
Crossref
Crossref
Article Editorial. (2018) Diagnosis and treatment of pulmonarydisease in α1-antitrypsin deficiency: a statement of European Respiratory Society. Russian Pulmonology 28:3, pages 273-295.
Crossref
Crossref
Sebastian Fähndrich, Nikolas Bernhard, Philipp Lepper & Robert Bals. (2018) Alpha-1-Antitrypsin-Mangel: Pathophysiologie, Diagnostik und Therapie. Pneumo News 10:2, pages 31-40.
Crossref
Crossref
Florie Borel, Huaming SunMarina ZiegerAndrew CoxBrynn CardozoWeiying LiGabriella OliveiraAiriel DavisAlisha GruntmanTerence R. FlotteMichael H. Brodsky, Andrew M. HoffmanMai K. ElmallahChristian Mueller. (2018)
Editing out five
Serpina1
paralogs to create a mouse model of genetic emphysema
. Proceedings of the National Academy of Sciences 115:11, pages 2788-2793.
Crossref
Crossref
Mariana N. Machado, Flavia Mazzoli-Rocha, Natália V. Casquilho, Tatiana Maron-Gutierrez, Victor H. Ortenzi, Marcelo M. Morales, Rodrigo S. Fortunato & Walter A. Zin. (2018) Bone Marrow-Derived Mononuclear Cell Therapy in Papain-Induced Experimental Pulmonary Emphysema. Frontiers in Physiology 9.
Crossref
Crossref
Gerard M. Turino. (2018) Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy. Annals of the American Thoracic Society 15:Supplement_1, pages S15-S17.
Crossref
Crossref
Haitham S. Al Ashry & Charlie Strange. (2017) COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. European Respiratory Review 26:146, pages 170068.
Crossref
Crossref
Yan LiMichael H. ChoXiaobo Zhou. (2017) What do polymorphisms tell us about the mechanisms of COPD?. Clinical Science 131:24, pages 2847-2863.
Crossref
Crossref
Karina Krotova, George W. Marek, Rejean L. Wang, George Aslanidi, Brad E. Hoffman, Nazli Khodayari, Farshid N. Rouhani & Mark L. Brantly. (2017) Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity. American Journal of Respiratory Cell and Molecular Biology 57:2, pages 238-247.
Crossref
Crossref
Younis Mohammad Hazari, Arif Bashir, Mudasir Habib, Samirul Bashir, Huma Habib, M. Abul Qasim, Naveed Nazir Shah, Ehtishamul Haq, Jeffrey Teckman & Khalid Majid Fazili. (2017) Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions. Mutation Research/Reviews in Mutation Research 773, pages 14-25.
Crossref
Crossref
Craig P. Hersh. (2017) Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine. F1000Research 6, pages 2049.
Crossref
Crossref
Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla & Claus Franz Vogelmeier. (2017)
The prevalence of diagnosed α
1
-antitrypsin deficiency and its comorbidities: results from a large population-based database
. European Respiratory Journal 49:1, pages 1600154.
Crossref
Crossref
Gang Huang, Xu-Chen Xu, Jie-Sen Zhou, Zhou-Yang Li, Hai-Pin Chen, Yong Wang, Wen Li, Hua-Hao Shen & Zhi-Hua Chen. (2017) Neutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models. Journal of Immunology Research 2017, pages 1-9.
Crossref
Crossref
Carina Kärrman Mårdh, James Root, Mohib Uddin, Kristina Stenvall, Anna Malmgren, Kostas Karabelas & Matthew Thomas. (2017) Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease. Journal of Immunology Research 2017, pages 1-13.
Crossref
Crossref
Camille de Seynes, C. Ged, H. de Verneuil, N. Chollet, M. Balduyck & C. Raherison. (2017) Identification of a novel alpha1-antitrypsin variant. Respiratory Medicine Case Reports 20, pages 64-67.
Crossref
Crossref
Ignacio Blanco. 2017. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Blanco's Overview of Alpha-1 Antitrypsin Deficiency
193
206
.
Charlie Strange. 2017. Alpha-1-antitrypsin Deficiency. Alpha-1-antitrypsin Deficiency
207
211
.
James K. Stoller. 2017. Alpha-1-antitrypsin Deficiency. Alpha-1-antitrypsin Deficiency
133
158
.
Ji-Hyun Lee. 2017. COPD. COPD
35
54
.
Catherine M. Greene, Stefan J. Marciniak, Jeffrey Teckman, Ilaria Ferrarotti, Mark L. Brantly, David A. Lomas, James K. Stoller & Noel G. McElvaney. (2016) α1-Antitrypsin deficiency. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Nasim Nosoudi, Vaideesh Parasaram, Saketh Karamched, Aniqa Chowdhury & Naren Vyavahare. 2016. Elastic Fiber Matrices. Elastic Fiber Matrices
189
226
.
Kuniaki Seyama, Toyohiro Hirai, Michiaki Mishima, Koichiro Tatsumi & Masaharu Nishimura. (2016) A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan. Respiratory Investigation 54:3, pages 201-206.
Crossref
Crossref
Timm Greulich & Claus F. Vogelmeier. (2015) Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis. Therapeutic Advances in Respiratory Disease 10:1, pages 72-84.
Crossref
Crossref
V. Margelidon-Cozzolino, K. Chbini, N. Freymond, G. Devouassoux, A. Belaaouaj & Y. Pacheco. (2016) La BPCO?: une maladie qui commence pr?cocement. Revue de Pneumologie Clinique 72:1, pages 49-60.
Crossref
Crossref
A.K. Kheirallah, S. Miller, I.P. Hall & I. Sayers. 2016.
57
145
.
Timm Greulich. 2016. Seltene Lungenerkrankungen. Seltene Lungenerkrankungen
369
383
.
Rachel Stevens. (2015) Therapy for Alpha-1 Antitrypsin Deficiency: The Evidence for Efficacy. EMJ Respiratory, pages 55-62.
Crossref
Crossref
Joanna WozniakTomasz WandtkePiotr KopinskiJoanna Chorostowska-Wynimko. (2015) Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy. Human Gene Therapy 26:11, pages 709-718.
Crossref
Crossref
Arunava Ghosh, R. C. Boucher & Robert Tarran. (2015) Airway hydration and COPD. Cellular and Molecular Life Sciences 72:19, pages 3637-3652.
Crossref
Crossref
Tine H. Malling, Line Sloth Carlsen, Ilaria Ferrarotti & Øyvind Omland. (2014)
Rare α
1
-antitrypsin genotype in a grass seed worker
. European Respiratory Journal 44:6, pages 1703-1704.
Crossref
Crossref
Sang Hoon Song, Minje Han, Yang Seon Choi, Ki Soon Dan, Man Gil Yang, Junghan Song, Sung Sup Park & Jae Ho Lee. (2014) Proteomic Profiling of Serum from Patients with Tuberculosis. Annals of Laboratory Medicine 34:5, pages 345-353.
Crossref
Crossref
Ignacio Blanco. (2014)
Oxidant-mediated Aggregation of Z α
1
-Antitrypsin in Pulmonary Epithelial Cells Amplifies Lung Inflammation
. American Journal of Respiratory and Critical Care Medicine 189:8, pages 877-879.
Crossref
Crossref
Jean-François Mornex. (2014) Le déficit en alpha-1 antitrypsine 50 ans après sa découverte. Bulletin de l'Académie Nationale de Médecine 198:4-5, pages 757-766.
Crossref
Crossref
Neil J. Kelly & Steven D. Shapiro. (2014) PPARγ in emphysema: blunts the damage and triggers repair?. Journal of Clinical Investigation 124:3, pages 978-980.
Crossref
Crossref
Yang XiangUlrike KogelStephan GebelMichael J. PeckManuel C. PeitschViatcheslav R. AkmaevJulia Hoeng. (2014) Discovery of Emphysema Relevant Molecular Networks from an A/J Mouse Inhalation Study Using Reverse Engineering and Forward Simulation (REFS™). Gene Regulation and Systems Biology 8, pages GRSB.S13140.
Crossref
Crossref
Jessica Bon, Serena Liao, George Tseng & Frank C. Sciurba. (2013) Considerations and pitfalls in phenotyping and reclassification of chronic obstructive pulmonary disease. Translational Research 162:4, pages 252-257.
Crossref
Crossref